HEALTH● LOWAug 13 · Aug 13, 2026, 4:48 AM
Biocardia outlines Japan CardiAMP Shonin submission next quarter with approval expected about 12 months later
Seeking Alpha Tech
Biocardia plans to submit its Japan CardiAMP Shonin next quarter, with approval anticipated approximately 12 months later. This outlines a key regulatory milestone for the company's medical technology.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH58m agoHealth authorities warn people with head injuries to avoid public waterbodiesThe HinduHEALTH1h agoNovartis scraps ALS therapy after mid-stage trial setbackSeeking Alpha TechHEALTH1h agoFifteen years of UK aid ‘gave 3 million healthcare and prevented 2 million unplanned pregnancies’ in MalawiThe Independent WorldHEALTH1h agoWeight loss drug side effects fuel sales boom for Advil-maker HaleonThe Independent World